We are pleased to introduce the second edition of our « Best of » series!
This edition is a summary of the latest scientific research on the gut microbiota and inflammatory bowel disease (IBD). It is a selection of content from the ESNM’s Gut Microbiota for Health website, compiled and edited by Prof. Philippe Marteau and Harry Sokol, in partnership with the European Crohn’s and Colitis Organisation (ECCO-IBD).
IBD research has made some exciting progress in the past decade, thanks to the myriad studies investigating the role of the gut microbiota. The Gut Microbiota for Health Experts Exchange has covered Crohn’s disease and ulcerative colitis more than any other topics and, reflecting the importance of intestinal microbiota in IBD.
In this document, you’ll have a picture of how probiotics, genes, the immune system, the intestinal microbiota, and environmental triggers might interact in the onset and course of IBD in both adult and pediatric populations.
Patients, doctors, associations, we also present in the document a list of the most influential Twitter accounts in the field of IBD.
Paul Enck Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany.
His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions.
He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.